Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

9.150 -0.370 (-3.89%)
Streaming Delayed Price Updated: 2:10 PM EDT, May 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
31 32 Next >
News headline image
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials ↗
Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress.... 
Via Benzinga
News headline image
Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript ↗
CMPS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
From COMPASS Pathways
Via GlobeNewswire
News headline image
Psychedelic Stock Gainers And Losers From February 27, 2023 ↗
 
Via Benzinga
News headline image
Earnings Preview: Compass Pathways ↗
 
Via Benzinga
News headline image
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD ↗
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 23, 2023 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 22, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 21, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 20, 2023 ↗
 
Via Benzinga
News headline image
John Oliver's Take On Psychedelic Assisted Therapy: There's Huge Potential If Done Responsibly ↗
John Oliver is back on "Last Week Tonight" and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic-assisted therapy. The show, which aired on Sunday,... 
Via Benzinga
News headline image
"Rags-To-Riches" Portfolio Underperforming YTD ↗
The munKNEE 
Via Talk Markets
News headline image
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD ↗
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
News headline image
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 15, 2023 ↗
 
Via Benzinga
News headline image
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
News headline image
7 Long-Term Stocks to Buy With Your Tax Refund ↗
Although you might want to spend your tax refund, a better approach is to target compelling long-term stocks to buy. 
Via InvestorPlace
News headline image
Major Psychedelic Compound-Based Stocks UP 13% YTD ↗
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
News headline image
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 8, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 7, 2023 ↗
 
Via Benzinga
News headline image
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
News headline image
7 Tempting Sin Stocks to Buy for Promising Profits ↗
After a rough time in 2022, investors may want to consider sin stocks to buy for a cynical shot at significant upside potential. 
Via InvestorPlace
News headline image
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.